SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Skye
Lv5
1150 积分
2023-11-16 加入
最近求助
最近应助
互助留言
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
6天前
已完结
A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer
16天前
已完结
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial
23天前
已完结
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer
25天前
已完结
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
25天前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
26天前
已完结
Pyrotinib plus capecitabine for human epidermal growth factor receptor 2-positive metastatic breast cancer after trastuzumab and taxanes (PHENIX): a randomized, double-blind, placebo-controlled phase 3 study
27天前
已完结
Adherence challenges in breast cancer: Evaluating tamoxifen and aromatase inhibitors in adjuvant hormone therapy
2个月前
已完结
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Breast Cancer. Version 2. 2024
2个月前
已关闭
真实世界研究在国产仿制药临床疗效与安全性评价中的应用及展望
2个月前
已完结
没有进行任何应助
感谢,点赞,速度真快
6天前
请问是只能找到预印吗
6天前
感谢,点赞,速度真快,帮大忙了
16天前
感谢,点赞,速度真快,帮大忙了
23天前
感谢,点赞,速度真快,帮大忙了
25天前
感谢,点赞,速度真快,帮大忙了
25天前
感谢,点赞,速度真快
26天前
感谢,速度真快,点赞
27天前
摘要书还需要求助吗?这根本就不是我要的那篇
2个月前
我要的是2024年3.1发表的,是全文,我上传的doi也是全文的,而且两篇文章的作者都不一样怎么能认定为同一篇???
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论